Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Clinical trial NCT05065736 · TERMINATED
Trial details
- NCT number
- NCT05065736
- Sponsor
- Roberto Vargas
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-05-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.